{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:57:20Z","timestamp":1791892640986,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1007\/s11926-000-0021-y","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T20:24:53Z","timestamp":1180729493000},"page":"459-465","source":"Crossref","is-referenced-by-count":369,"title":["Osteoarthritis and cartilage: The role of cytokines"],"prefix":"10.1007","volume":"2","author":[{"given":"Mary B.","family":"Goldring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"21_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03008209909005273","volume":"40","author":"MB Goldring","year":"1999","unstructured":"Goldring MB: The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 1999, 40:1\u201311.","journal-title":"Connect Tissue Res"},{"key":"21_CR2","doi-asserted-by":"crossref","unstructured":"Goldring MB: The role of the chondrocyte in osteoarthritis. Arthritis Rheum 2000, In press.","DOI":"10.1002\/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I"},{"key":"21_CR3","first-page":"255","volume-title":"Arthritis and Allied Conditions: A Textbook of Rheumatology","author":"AR Poole","year":"1997","unstructured":"Poole AR: Cartilage in health and disease. In Arthritis and Allied Conditions: A Textbook of Rheumatology. Edited by Koopman WJ. Baltimore: Williams & Wilkins; 1997:255\u2013308."},{"key":"21_CR4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/ard.56.5.287","volume":"56","author":"T Aigner","year":"1997","unstructured":"Aigner T, Dudhia J: Phenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis: a hypothesis. Ann Rheum Dis 1997, 56:287\u2013291.","journal-title":"Ann Rheum Dis"},{"key":"21_CR5","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/1529-0131(199907)42:7<1443::AID-ANR18>3.0.CO;2-A","volume":"42","author":"T Aigner","year":"1999","unstructured":"Aigner T, Zhu Y, Chansky HH, et al.: Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage. Arthritis Rheum 1999, 42:1443\u20131450.","journal-title":"Arthritis Rheum"},{"key":"21_CR6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/1529-0131(200005)43:5<953::AID-ANR1>3.0.CO;2-Q","volume":"43","author":"P Garnero","year":"2000","unstructured":"Garnero P, Rousseau J-C, Delmas PD: Molecular basis and clinical use of biochemical markers of bone, cartilage and synovium in joint diseases. Arthritis Rheum 2000, 43:953\u2013968.","journal-title":"Arthritis Rheum"},{"key":"21_CR7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1529-0131(199901)42:1<129::AID-ANR16>3.0.CO;2-4","volume":"42","author":"N Ishiguro","year":"1999","unstructured":"Ishiguro N, Ito T, Ito H, et al.: Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis. Arthritis Rheum 1999, 42:129\u2013136.","journal-title":"Arthritis Rheum"},{"key":"21_CR8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/ard.59.6.455","volume":"59","author":"Y Yoshihara","year":"2000","unstructured":"Yoshihara Y, Nakamura H, Obata K, et al.: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 2000, 59:455\u2013461. Matrix metalloproteinases and TIMPs were detected at lower levels in OA patients and in less than 20% of OA compared with 45% of RA synovial fluids.","journal-title":"Ann Rheum Dis"},{"key":"21_CR9","doi-asserted-by":"crossref","first-page":"D662","DOI":"10.2741\/A463","volume":"4","author":"AR Poole","year":"1999","unstructured":"Poole AR: An Introduction to the pathophysiology of osteoarthritis. Frontiers Biosci 1999, 4:D662\u2013670. This recent review and other papers in this volume provide an excellent overview of the field and may be read online at http:\/\/www.bioscience.org\/1999\/v4\/d.","journal-title":"Frontiers Biosci"},{"key":"21_CR10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/1529-0131(200003)43:3<673::AID-ANR25>3.0.CO;2-8","volume":"43","author":"L Dahlberg","year":"2000","unstructured":"Dahlberg L, Billinghurst RC, Manner P, et al.: Selective enhancement of collagenase-mediated cleavage of resident of type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis Rheum 2000, 43:673\u2013682. This and the companion paper by Billinghurst et al. (Arthritis Rheum 2000, 43:664-672) show that digestion of type II collagen is selectively increased in OA cartilage and demonstrate the use of selective MMP inhibitors and epitope-specific antibodies for analyzing mechanisms of OA cartilage degradation.","journal-title":"Arthritis Rheum"},{"key":"21_CR11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/bj3440061","volume":"344","author":"CB Little","year":"1999","unstructured":"Little CB, Flannery CR, Hughes CE, et al.: Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J 1999, 344:61\u201368.","journal-title":"Biochem J"},{"key":"21_CR12","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.284.5420.1664","volume":"284","author":"MD Tortorella","year":"1999","unstructured":"Tortorella MD, Burn TC, Pratta MA, et al.: Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 1999, 284:1664\u20131666.","journal-title":"Science"},{"key":"21_CR13","doi-asserted-by":"crossref","first-page":"23443","DOI":"10.1074\/jbc.274.33.23443","volume":"274","author":"I Abbaszade","year":"1999","unstructured":"Abbaszade I, Liu RQ, Yang F, et al.: Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 1999, 274:23443\u201323450.","journal-title":"J Biol Chem"},{"key":"21_CR14","doi-asserted-by":"crossref","first-page":"D704","DOI":"10.2741\/A388","volume":"4","author":"RL Smith","year":"1999","unstructured":"Smith RL: Degradative enzymes in osteoarthritis. Frontiers Biosci 1999, 4:D704\u2013712.","journal-title":"Frontiers Biosci"},{"key":"21_CR15","first-page":"1007","volume":"379","author":"A Baici","year":"1998","unstructured":"Baici A: Inhibition of extracellular matrix-degrading endopeptidases: problems, comments, and hypotheses. Biol Chem 1998, 379:1007\u20131018.","journal-title":"Biol Chem"},{"key":"21_CR16","doi-asserted-by":"crossref","first-page":"D713","DOI":"10.2741\/A389","volume":"4","author":"GA Homandberg","year":"1999","unstructured":"Homandberg GA: Potential regulation of cartilage metabolism in osteoarthritis by fibronectin fragments. Frontiers Biosci 1999, 4:D713\u2013730.","journal-title":"Frontiers Biosci"},{"key":"21_CR17","first-page":"281","volume-title":"Joint Cartilage Degradation: Basic and Clinical Aspects","author":"MB Goldring","year":"1993","unstructured":"Goldring MB: Degradation of articular cartilage in culture: regulatory factors. In Joint Cartilage Degradation: Basic and Clinical Aspects. Edited by Woessner JFJr, Howell DS. New York: Marcel Dekker, Inc.; 1993:281\u2013345."},{"key":"21_CR18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0049-0172(96)80036-9","volume":"25","author":"CI Westacott","year":"1996","unstructured":"Westacott CI, Sharif M: Cytokines in osteoarthritis: mediators or markers of joint destruction? Sem in Arthritis Rheum 1996, 25:254\u2013272.","journal-title":"Sem in Arthritis Rheum"},{"key":"21_CR19","doi-asserted-by":"crossref","first-page":"I40","DOI":"10.1136\/ard.58.2008.i40","volume":"58","author":"WB Berg van den","year":"1999","unstructured":"van den BergWB, Joosten LA, Kollias G, van De LooFA: Role of tumour necrosis factor ? in experimental arthritis: separate activity of interleukin 1? in chronicity and cartilage destruction. Ann Rheum Dis 1999, 58:I40-I48. This and other articles in this supplement summarize the current consensus on the use of TNF-a blocking agents for arthritis therapy.","journal-title":"Ann Rheum Dis"},{"key":"21_CR20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1359-6101(98)00018-5","volume":"9","author":"PE Auron","year":"1998","unstructured":"Auron PE: The interleukin 1 receptor: Ligand interactions and signal transduction. Cytokine Growth Factor Rev 1998, 9:221\u2013237. Excellent review of structure-function relationships of IL-1 ligands and receptors.","journal-title":"Cytokine Growth Factor Rev"},{"key":"21_CR21","first-page":"155","volume":"14","author":"JF Schlaak","year":"1996","unstructured":"Schlaak JF, Pfers I, Meyer Zum Buschenfelde KH, Marker- Hermann E: Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin Exp Rheumatol 1996, 14:155\u2013162.","journal-title":"Clin Exp Rheumatol"},{"key":"21_CR22","first-page":"870","volume":"26","author":"V Moos","year":"1999","unstructured":"Moos V, Fickert S, Muller B, et al.: Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. J Rheumatol 1999, 26:870\u2013879.","journal-title":"J Rheumatol"},{"key":"21_CR23","doi-asserted-by":"crossref","first-page":"D694","DOI":"10.2741\/A387","volume":"4","author":"J Martel-Pelletier","year":"1999","unstructured":"Martel-Pelletier J, Alaaeddine N, Pelletier J-P: Cytokines and their role in the pathophysiology of osteoarthritis. Frontiers Biosci 1999, 4:D694-D703.","journal-title":"Frontiers Biosci"},{"key":"21_CR24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.immunol.16.1.27","volume":"16","author":"WP Arend","year":"1998","unstructured":"Arend WP, Malyak M, Guthridge CJ, Gabay C: Interleukin-1 receptor antagonist: role in biology. Ann Rev Immunol 1998, 16:27\u201355.","journal-title":"Ann Rev Immunol"},{"key":"21_CR25","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2460\/ajvr.1997.58.09.1027","volume":"58","author":"CW Hay","year":"1997","unstructured":"Hay CW, Chu Q, Budsberg SC, et al.: Synovial fluid interleukin 6, tumor necrosis factor, and nitric oxide values in dogs with osteoarthritis secondary to cranial cruciate ligament rupture. Am J Vet Res 1997, 58:1027\u20131032.","journal-title":"Am J Vet Res"},{"key":"21_CR26","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.4049\/jimmunol.160.9.4570","volume":"160","author":"IR Patel","year":"1998","unstructured":"Patel IR, Attur MG, Patel RN, et al.: TNF-a convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-a. J Immunol 1998, 160:4570\u20134579.","journal-title":"J Immunol"},{"issue":"suppl I","key":"21_CR27","doi-asserted-by":"crossref","first-page":"I27","DOI":"10.1136\/ard.58.2008.i27","volume":"58","author":"M Feldman","year":"1999","unstructured":"Feldman M, Bondeson J, Brennan FM, et al.: The rationale for the current boom in anti-TNF-a treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNF-a and minimize hazards? Ann Rheum Dis 1999, 58(suppl I):I27-I31.","journal-title":"Ann Rheum Dis"},{"key":"21_CR28","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/art.1780400604","volume":"40","author":"J-P Pelletier","year":"1997","unstructured":"Pelletier J-P, Caron JP, Evans C, et al.: In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 1997, 40:1012\u20131019.","journal-title":"Arthritis Rheum"},{"key":"21_CR29","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1089\/hum.1996.7.10-1261","volume":"7","author":"CH Evans","year":"1996","unstructured":"Evans CH, Robbins PD, Ghivizzani SC, et al.: Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 1996, 7:1261\u20131280.","journal-title":"Hum Gene Ther"},{"key":"21_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1529-0131(199901)42:1<1::AID-ANR1>3.0.CO;2-4","volume":"42","author":"CH Evans","year":"1999","unstructured":"Evans CH, Ghivizzani SC, Kang R, et al.: Gene therapy for rheumatic diseases. Arthritis Rheum 1999, 42:1\u201316.","journal-title":"Arthritis Rheum"},{"key":"21_CR31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00002281-199705000-00008","volume":"9","author":"WB Berg van den","year":"1997","unstructured":"van den BergWB: Lessons for joint destruction from animal models. Curr Opin Rheumatol 1997, 9:221\u2013228.","journal-title":"Curr Opin Rheumatol"},{"key":"21_CR32","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/art.1780400614","volume":"40","author":"H Okamoto","year":"1997","unstructured":"Okamoto H, Yamamura M, Morita Y, et al.: The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Arthritis Rheum 1997, 40:1096\u20131105.","journal-title":"Arthritis Rheum"},{"key":"21_CR33","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1006\/cyto.1999.0505","volume":"11","author":"N Alaaeddine","year":"1999","unstructured":"Alaaeddine N, Di Battista JA, Pelletier JP, et al.: Differential effects of IL-8, LIF (pro-inflammatory) and IL-11 (anti-inflammatory) on TNF-a-induced PGE2 release and on signalling pathways in human OA synovial fibroblasts. Cytokine 1999, 11:1020\u20131030.","journal-title":"Cytokine"},{"key":"21_CR34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.1999.tb07678.x","volume":"878","author":"TE Cawston","year":"1999","unstructured":"Cawston TE, Billington C, Cleaver C, et al.: The regulation of MMPs and TIMPs in cartilage turnover. N Y Acad Sci 1999, 878:120\u2013129.","journal-title":"N Y Acad Sci"},{"key":"21_CR35","first-page":"177","volume":"151","author":"FA Loo van de","year":"1997","unstructured":"van de LooFA, Kuiper S, van EnckevortFH, et al.: Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice. Am J Pathol 1997, 151:177\u2013191.","journal-title":"Am J Pathol"},{"key":"21_CR36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0945-053X(99)00021-9","volume":"18","author":"PA Guerne","year":"1999","unstructured":"Guerne PA, Desgeorges A, Jaspar J-M, et al.: Effects of IL-6 and its soluble receptor on proteoglycan synthesis and NO release by human articular chondrocytes: comparison with IL-1. Modulation by dexamethasone. Matrix Biol 1999, 18:253\u2013260.","journal-title":"Matrix Biol"},{"key":"21_CR37","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/1529-0131(199908)42:8<1577::AID-ANR3>3.0.CO;2-Z","volume":"42","author":"N Saha","year":"1999","unstructured":"Saha N, Moldovan F, Tardif G, et al.: Interleukin-1a-converting enzyme\/caspase-1 in human osteoarthritic tissues: localization and role in the maturation of interleukin-1a and interleukin-18. Arthritis Rheum 1999, 42:1577\u20131587.","journal-title":"Arthritis Rheum"},{"key":"21_CR38","doi-asserted-by":"crossref","first-page":"27467","DOI":"10.1074\/jbc.273.42.27467","volume":"273","author":"T Shalom-Barak","year":"1998","unstructured":"Shalom-Barak T, Quach J, Lotz M: Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kB. J Biol Chem 1998, 273:27467\u201327473.","journal-title":"J Biol Chem"},{"key":"21_CR39","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4049\/jimmunol.162.2.1096","volume":"162","author":"T Olee","year":"1999","unstructured":"Olee T, Hashimoto S, Quach J, Lotz M: IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J Immunol 1999, 162:1096\u20131100.","journal-title":"J Immunol"},{"key":"21_CR40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/clin.1997.4441","volume":"85","author":"JM Woods","year":"1997","unstructured":"Woods JM, Haines GK, Shah MR, et al.: Low-level production of interleukin-13 in synovial fluid and tissue from patients with arthritis. Clin Immunol Immunopathol 1997, 85:210\u2013220.","journal-title":"Clin Immunol Immunopathol"},{"key":"21_CR41","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/1529-0131(199904)42:4<710::AID-ANR14>3.0.CO;2-4","volume":"42","author":"N Alaaeddine","year":"1999","unstructured":"Alaaeddine N, Di Battista JA, Pelletier JP, et al.: Inhibition of tumor necrosis factor a-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways. Arthritis Rheum 1999, 42:710\u2013718.","journal-title":"Arthritis Rheum"},{"key":"21_CR42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/cyto.1997.0298","volume":"10","author":"E Lubberts","year":"1998","unstructured":"Lubberts E, Joosten LA, Helsen MM, van den BergWB: Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4\/IL-10 combination therapy than with IL-10 treatment alone. Cytokine 1998, 10:361\u2013369.","journal-title":"Cytokine"},{"key":"21_CR43","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.4049\/jimmunol.163.8.4546","volume":"163","author":"E Lubberts","year":"1999","unstructured":"Lubberts E, Joosten LA, van den BersselaarL, et al.: Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J Immunol 1999, 163:4546\u20134556.","journal-title":"J Immunol"},{"key":"21_CR44","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/1529-0131(199904)42:3<490::AID-ANR14>3.0.CO;2-L","volume":"42","author":"U Muller-Ladner","year":"1999","unstructured":"Muller-Ladner U, Evans CH, Franklin BN, et al.: Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model. Arthritis Rheum 1999, 42:490\u2013497.","journal-title":"Arthritis Rheum"},{"key":"21_CR45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0009-9120(98)00062-9","volume":"31","author":"P Trontzas","year":"1998","unstructured":"Trontzas P, Kamper EF, Potamianou A, et al.: Comparative study of serum and synovial fluid interleukin-11 levels in patients with various arthritides. Clin Biochem 1998, 31:673\u2013679.","journal-title":"Clin Biochem"},{"key":"21_CR46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1367-5931(99)80071-4","volume":"3","author":"AJ Lewis","year":"1999","unstructured":"Lewis AJ, Manning AM: New targets for anti-inflammatory drugs. Curr Opin Chem Biol 1999, 3:489\u2013494.","journal-title":"Curr Opin Chem Biol"},{"key":"21_CR47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/1529-0131(200001)43:1<175::AID-ANR22>3.0.CO;2-S","volume":"43","author":"AM Badger","year":"2000","unstructured":"Badger AM, Griswold DE, Kapadia R, et al.: Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis Rheum 2000, 43:175\u2013183.","journal-title":"Arthritis Rheum"},{"key":"21_CR48","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J","volume":"42","author":"JA Buckwalter","year":"1998","unstructured":"Buckwalter JA, Mankin HJ: Articular cartilage repair and transplantation. Arthritis Rheum 1998, 42:1331\u20131342.","journal-title":"Arthritis Rheum"},{"key":"21_CR49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s000110050288","volume":"47","author":"J Martel-Pelletier","year":"1998","unstructured":"Martel-Pelletier J, Di Battista JA, Lajeunesse D, Pelletier J-P: IGF\/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis. Inflamm Res 1998, 47:90\u2013100.","journal-title":"Inflamm Res"},{"key":"21_CR50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nbt0398-247","volume":"16","author":"AH Reddi","year":"1998","unstructured":"Reddi AH: Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nature Biotech 1998, 16:247\u2013252.","journal-title":"Nature Biotech"},{"key":"21_CR51","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2106\/00004623-199812000-00004","volume":"80","author":"JU Yoo","year":"1998","unstructured":"Yoo JU, Barthel TS, Nishimura K, et al.: The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 1998, 80:1745\u20131757.","journal-title":"J Bone Joint Surg Am"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-000-0021-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-000-0021-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-000-0021-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T13:44:17Z","timestamp":1707918257000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-000-0021-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["21"],"URL":"https:\/\/doi.org\/10.1007\/s11926-000-0021-y","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}